Here we go again, the bubble fever is back! Here we go again, the bubble fever is back! Here we go again, the bubble fever is back!

Here we go again, the bubble fever is back!

Equities 5 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Key Points:

  • Strong start to the year: The S&P 500 is up 6.5%, nearly a year's worth of normal returns, driven by optimism and booming AI and obesity themes.

  • Concerns about overvaluation: Nvidia's recent success and high valuations in US equities raise concerns of a potential bubble similar to the dot-com era.

  • Negative real returns possible: Historically, similar valuation levels have led to negative real returns after accounting for inflation.

  • Recommendations for investors: Diversify away from US equities, consider bonds, European stocks, dividend stocks, or hedging strategies.

A year’s return in just two months

The equity market momentum has been incredible driven by the continuous realisation over the past year that a US economic recession was not coming and that certain sectors of the economy was in fact booming. This year alone the S&P 500 Index is up 6.5% including reinvestment of dividends, so almost an entire year of normal equity returns has been delivered to investors in just two months.

S&P 500 | Source: Saxo

With Nvidia’s extraordinary results and outlook last week captivating investors and their grandiose statement that generative AI has reached a “tipping point” might be exactly the signal that confirms that the equity market is getting too hot.

Last year we said that equity valuations were not a concern for global equities but US equities were getting increasingly stretched. However, when you have an AI hype then things can get really stretched and our view is now that we have entered a dangerous level again in US equities. As our valuation chart below shows, US equities are now significantly more expensive compared to the average valuation since 1992. In fact, US equities have now reached levels we have only observed during the dot-com bubble and the 2021 technology bubble during the pandemic.

If we take a look at the seven metrics going into the combined valuation metric then we can see that it is really the price-to-sales, EV-to-EBITDA, price-to-cash-flow, and EV-to-sales that are pushing US equities into overvaluation levels. The price investors are willing to pay for sales has been driven by technology companies increasingly dominating the US equity indices because US technology companies have a higher profit margin. The higher the profit margin the more investors are willing to pay for a dollar of revenue. This naturally leads to the conclusions that a lot of the current price level in US equities hinges on assumptions that US technology companies can maintain their abnormally high profit margin.

Could we really have a decade of negative real returns in equities?

Our discussion about US equity valuations become even more concerning when we take the equity valuation level today and go back in time to see what that level meant for future returns. The future returns we can lean on is those that came after the dot-com bubble, and here the picture is clear, when you get to these equity valuation levels future returns after subtracting inflation become negative. Can investors really expect that again this time?

The US equity market peaked in terms of equity valuation in December 2021 which was just before the big readjustment of equity valuations as interest rates began to ascent getting the point from the Fed that inflation was more entrenched that initially thought. We are now 26 months into this cycle of investing in US equities from an alarmingly high starting point in terms of valuation. Since December 2021, the S&P 500 Index has returned 2.4% annualised while US inflation has risen 5% annualised over the same period. So already a bit more than 20% into this new period of future returns from levels that even exceeded those during the dot-com bubble, we  are seeing equities falling behind delivering a negative annualised real return of 2.6%. It is our fiduciary responsibility as market professionals to warn investors about the current dynamics in US equities.

What should investors do?

For investors it means that it is probably a good idea to act on what we are seeing in the equity market. Our view is that it is always best to be invested so investors should increase their cash position, but instead think about how to diversify their portfolio to mitigate the valuation risk in US equities and in particular US technology stocks. Here are a couple of options to consider:

  • Reduce exposure to equities and increase exposure to bonds in order to reduce portfolio risk.

  • Reduce exposure to US equities and Increase exposure to European equities which have a less cyclical profile and lower equity valuation.

  • Increase exposure to dividend stocks as they will likely be less volatile should the equity market begin to reduce lower US equity valuations.
For those that have the long-term stocks they want, one could consider temporarily hedge their portfolio by selling a CFD on the S&P 500 or buy a put option on the S&P 500 (the at-the-money puts on S&P 500 with expiry on 20 December 2024 costs roughly 4%).
Disclaimer

The Saxo Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website is not intended to and does not change or expand on this. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-hk/legal/disclaimer/saxo-disclaimer)

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments. Saxo does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo or its affiliates.

Saxo Capital Markets HK Limited
19th Floor
Shanghai Commercial Bank Tower
12 Queen’s Road Central
Hong Kong

Contact Saxo

Select region

Hong Kong S.A.R
Hong Kong S.A.R

Saxo Capital Markets HK Limited (“Saxo”) is a company authorised and regulated by the Securities and Futures Commission of Hong Kong. Saxo holds a Type 1 Regulated Activity (Dealing in Securities); Type 2 Regulated Activity (Dealing in Futures Contract); Type 3 Regulated Activity (Leveraged Foreign Exchange Trading); Type 4 Regulated Activity (Advising on Securities) and Type 9 Regulated Activity (Asset Management) licenses (CE No. AVD061). Registered address: 19th Floor, Shanghai Commercial Bank Tower, 12 Queen’s Road Central, Hong Kong.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products may result in your losses exceeding your initial deposits. Saxo does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo does not take into account an individual’s needs, objectives or financial situation. Please click here to view the relevant risk disclosure statements.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-hk/about-us/awards.

The information or the products and services referred to on this site may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and services offered on this website are not directed at, or intended for distribution to or use by, any person or entity residing in the United States and Japan. Please click here to view our full disclaimer.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc. Android is a trademark of Google Inc.